Farther Finance Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.85M Buy
37,340
+2,826
+8% +$424K 0.05% 359
2026
Q1
$5.35M Buy
34,514
+136
+0.4% +$20.8K 0.05% 328
2025
Q4
$4.74M Buy
34,378
+16,069
+88% +$2.1M 0.05% 318
2025
Q3
$2.35M Buy
18,309
+981
+6% +$120K 0.04% 399
2025
Q2
$2.1M Buy
17,328
+1,700
+11% +$192K 0.04% 352
2025
Q1
$1.71M Buy
15,628
+3,389
+28% +$361K 0.04% 344
2024
Q4
$1.19M Sell
12,239
-961
-7% -$102K 0.04% 316
2024
Q3
$1.52M Buy
13,200
+2,717
+26% +$308K 0.06% 247
2024
Q2
$1.12M Buy
10,483
+1,769
+20% +$178K 0.05% 277
2024
Q1
$835K Buy
8,714
+1,375
+19% +$141K 0.05% 288
2023
Q4
$741K Buy
7,339
+6,141
+513% +$593K 0.05% 274
2023
Q3
$122K Buy
1,198
+662
+124% +$67.2K 0.02% 498
2023
Q2
$54.1K Sell
536
-578
-52% -$57.8K 0.01% 644
2023
Q1
$102K Buy
1,114
+786
+240% +$68.6K 0.03% 401
2022
Q4
$29.8K Buy
+328
New +$27.6K 0.01% 613

Other funds holding NVS

Farther Finance Advisors's NVS Position: Q2 2026 in Review

Farther Finance Advisors increased its Novartis (NVS) stake by 8.2% in Q2 2026, buying an estimated $424K and bringing the position to 37,340 shares worth $5.85M. The position accounts for 0.05% of the portfolio, ranked #359.

Farther Finance Advisors first reported a position in NVS in Q4 2022 and has held it in 15 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Farther Finance Advisors held 37,340 shares of Novartis worth $5.85M as of Q2 2026.
  • Farther Finance Advisors bought 2,826 Novartis shares in Q2 2026, an estimated $424K.
  • Novartis made up 0.05% of Farther Finance Advisors's portfolio in Q2 2026, its #359 holding.
  • Farther Finance Advisors first reported a position in Novartis in Q4 2022 and has held it in 15 quarters since.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.